These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29941771)

  • 1. 5% cefuroxime as an alternative to 5% cefazolin in the treatment of Gram-positive bacterial keratitis.
    Chatterjee S; Agrawal D
    Indian J Ophthalmol; 2018 Jul; 66(7):1046-1048. PubMed ID: 29941771
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro susceptibility of bacterial keratitis isolates to fourth-generation fluoroquinolones.
    Chawla B; Agarwal P; Tandon R; Titiyal JS; Sharma N; Agarwal T; Navak N; Satpathy G
    Eur J Ophthalmol; 2010; 20(2):300-5. PubMed ID: 19924668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection.
    Kowalski RP; Kowalski TA; Shanks RM; Romanowski EG; Karenchak LM; Mah FS
    Cornea; 2013 Jun; 32(6):830-4. PubMed ID: 23132444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in resistance to ciprofloxacin, cefazolin, and gentamicin in the treatment of bacterial keratitis.
    Afshari NA; Ma JJ; Duncan SM; Pineda R; Starr CE; Decroos FC; Johnson CS; Adelman RA
    J Ocul Pharmacol Ther; 2008 Apr; 24(2):217-23. PubMed ID: 18331204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial keratitis in Waikato, New Zealand.
    Pandita A; Murphy C
    Clin Exp Ophthalmol; 2011 Jul; 39(5):393-7. PubMed ID: 21176039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twelve-year analysis of microbial keratitis trends at a UK tertiary hospital.
    Tan SZ; Walkden A; Au L; Fullwood C; Hamilton A; Qamruddin A; Armstrong M; Brahma AK; Carley F
    Eye (Lond); 2017 Aug; 31(8):1229-1236. PubMed ID: 28452995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of bacterial cultures in infectious keratitis, 1997 to 2004.
    Yeh DL; Stinnett SS; Afshari NA
    Am J Ophthalmol; 2006 Dec; 142(6):1066-8. PubMed ID: 17157596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolones in the treatment of bacterial keratitis.
    Bower KS; Kowalski RP; Gordon YJ
    Am J Ophthalmol; 1996 Jun; 121(6):712-5. PubMed ID: 8644818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shifting Trends in Bacterial Keratitis in Taiwan: A 10-Year Review in a Tertiary-Care Hospital.
    Hsiao CH; Sun CC; Yeh LK; Ma DH; Chen PY; Lin HC; Tan HY; Chen HC; Chen SY; Huang YC
    Cornea; 2016 Mar; 35(3):313-7. PubMed ID: 26764878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shifting trends in bacterial keratitis in Toronto: an 11-year review.
    Lichtinger A; Yeung SN; Kim P; Amiran MD; Iovieno A; Elbaz U; Ku JY; Wolff R; Rootman DS; Slomovic AR
    Ophthalmology; 2012 Sep; 119(9):1785-90. PubMed ID: 22627118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stromal abscess caused by Enterococcus fecalis: an unusual presentation.
    Subashini K; Arvind G; Sabyasachi S; Renuka S
    Indian J Ophthalmol; 2007; 55(2):160-1. PubMed ID: 17322617
    [No Abstract]   [Full Text] [Related]  

  • 12.
    Zhang H; Liu S; Yue J; Sun S; Lv Q; Jian S; Xie Y; Han L; Zhang F; Dai Y; Wang L
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antibiotic resistance in bacterial keratitis in London.
    Tuft SJ; Matheson M
    Br J Ophthalmol; 2000 Jul; 84(7):687-91. PubMed ID: 10873974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical Keratitis Caused by
    Williams B; Jafri M; Arfeen S; Reidy JJ; Hariprasad SM; Farooq AV
    Ocul Immunol Inflamm; 2021 Jan; 29(1):26-28. PubMed ID: 31580183
    [No Abstract]   [Full Text] [Related]  

  • 15. Gemella haemolysans infectious crystalline keratopathy.
    Munir WM; El Mallah MK; Janda WM; Tu EY
    Cornea; 2008 Feb; 27(2):258; author reply 258. PubMed ID: 18216595
    [No Abstract]   [Full Text] [Related]  

  • 16. Bacterial Keratitis in Toronto: A 16-Year Review of the Microorganisms Isolated and the Resistance Patterns Observed.
    Tam ALC; Côté E; Saldanha M; Lichtinger A; Slomovic AR
    Cornea; 2017 Dec; 36(12):1528-1534. PubMed ID: 28938380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual anaerobic bacteria in keratitis after laser in situ keratomileusis: diagnosis using molecular biology methods.
    Ferrer C; Rodríguez-Prats JL; Abad JL; Alió JL
    J Cataract Refract Surg; 2004 Aug; 30(8):1790-4. PubMed ID: 15313309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review.
    Orlans HO; Hornby SJ; Bowler IC
    Eye (Lond); 2011 Apr; 25(4):489-93. PubMed ID: 21252952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial spectrum and antimicrobial susceptibility patterns in acquired and connatal lacrimal duct stenosis.
    Prokosch V; Prokosch JE; Promesberger J; Idelevich EA; Böhm MR; Thanos S; Stupp T
    Curr Eye Res; 2014 Nov; 39(11):1069-75. PubMed ID: 24912091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious keratitis in South Australia: emerging resistance to cephazolin.
    Leibovitch I; Lai TF; Senarath L; Hsuan J; Selva D
    Eur J Ophthalmol; 2005; 15(1):23-6. PubMed ID: 15751235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.